This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1978.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1978
Title: Yvon G Perron: Innovator in Pharmaceutical Chemistry
Introduction
Yvon G Perron is a notable inventor based in St-Lambert, Canada. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new synthetic routes for drug production. His work has implications for the advancement of medical treatments and therapies.
Latest Patents
Yvon G Perron holds a patent for the production of a compound known as 7-(2-aminomethylphenylacetamido)-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid. This innovative synthetic route represents a valuable addition to the pharmaceutical industry, showcasing his expertise in chemical synthesis.
Career Highlights
Throughout his career, Yvon has been associated with Bristol-Myers Company, where he has applied his knowledge and skills to advance pharmaceutical research and development. His dedication to innovation has positioned him as a key figure in his field.
Collaborations
Yvon G Perron has collaborated with various professionals in the industry, including his coworker Gary M Lim. These partnerships have fostered an environment of creativity and innovation, leading to significant advancements in pharmaceutical chemistry.
Conclusion
Yvon G Perron's contributions to the field of pharmaceutical chemistry through his innovative patent and collaborations highlight his importance as an inventor. His work continues to influence the development of new medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile